Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2026-02-09

FDA Approved: ISOTRETINOIN — Supplemental Application (Upsher-Smith Laboratories, LLC)

View source ↗

Summary

FDA approved Upsher-Smith Laboratories' supplemental application for isotretinoin (ANDA213571).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ISOTRETINOIN (Isotretinoin)

Snippet

SUPPL AP for ISOTRETINOIN (ISOTRETINOIN)